Other
Neoplasm by Special Category
CI-CAN-00000004Explore in graph →
Non-malignant21,349 active trials259 approved drugs3,859 evidence items
- NCIt
- C7062
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000004Explore in graph →
Clinical trials
95,726 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00119340 | Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia | completed | Phase 1 / Phase 2 | 75 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00217529 | Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER |
| 1 |
| Sep 21, 2010 |
| clinicaltrials |
| NCT00248430 | Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer | completed | Phase 1 / Phase 2 | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00003081 | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma | completed | Phase 1 | 16 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 20, 2010 | clinicaltrials |
| NCT00107354 | Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 20, 2010 | clinicaltrials |
| NCT00541788 | Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation | completed | Phase 1 | 10 | University Hospital, GhentOTHER | 1 | Sep 17, 2010 | clinicaltrials |
| NCT00049634 | Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder | completed | Phase 1 / Phase 2 | 30 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT00002788 | High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | completed | Phase 1 | 15 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00002977 | Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission | completed | Phase 1 | 45 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00003080 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | completed | Phase 1 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00327600 | Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma | completed | Phase 1 / Phase 2 | 68 | AmpliMed CorporationINDUSTRY | 1 | Sep 15, 2010 | clinicaltrials |
| NCT00006086 | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer | completed | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00778128 | A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour | completed | Phase 1 | 26 | Clavis PharmaINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00001126 | Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) | completed | Phase 1 | 36 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Aug 27, 2010 | clinicaltrials |
| NCT00012207 | Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 1 | 12 | Fred Hutchinson Cancer CenterOTHER | 1 | Aug 24, 2010 | clinicaltrials |
| NCT00397293 | Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 36 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 24, 2010 | clinicaltrials |
| NCT00609011 | Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma | completed | Phase 1 / Phase 2 | 22 | Myrexis Inc.INDUSTRY | 1 | Aug 23, 2010 | clinicaltrials |
| NCT00705315 | Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00454103 | Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy | completed | Phase 1 / Phase 2 | — | University of WuerzburgOTHER | 1 | Aug 18, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00232440 | Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma | completed | Phase 1 / Phase 2 | 20 | University Health Network, TorontoOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT00002915 | Penclomedine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00003289 | UCN-01 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00047242 | UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00368914 | Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00692354 | Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours | completed | Phase 1 | 41 | Chroma TherapeuticsINDUSTRY | 0 | Aug 6, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00688090 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma. | completed | Phase 1 | 19 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00083460 | Study of Combination PS-341 and Thalidomide in Multiple Myeloma | completed | Phase 1 | 86 | University of ArkansasOTHER | 1 | Aug 2, 2010 | clinicaltrials |
| NCT00730470 | Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | U3 Pharma GmbHINDUSTRY | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00002604 | O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors | completed | Phase 1 | 28 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00004225 | Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | — | Eastern Cooperative Oncology GroupNETWORK | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00081757 | An Open Protocol for the Compassionate Use of Thalidomide | completed | Phase 1 / Phase 2 | 250 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00388089 | Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00126646 | BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma | completed | Phase 1 | 24 | MedImmune LLCINDUSTRY | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00002588 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | completed | Phase 1 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005593 | Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome | completed | Phase 1 | 31 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005642 | SU5416 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005819 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005822 | SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | completed | Phase 1 | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006018 | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006372 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006465 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00049296 | Thalidomide and Docetaxel in Treating Patients With Advanced Cancer | completed | Phase 1 | 26 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00253344 | Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005647 | SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck | completed | Phase 1 | 12 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Sep 21, 2010source: clinicaltrials